Same Indication

Nivolumab vs Pantoprazole

Nivolumab vs Pantoprazole: Overview

This comparison examines the pharmacological differences between Nivolumab and Pantoprazole.

Mechanism of Action

Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

Pantoprazole: Proton pump inhibitor.

Pharmacokinetics

Half-life: Nivolumab β€” 27 days; Pantoprazole β€” 1 hour.

Chemical Properties

Molecular Formula: Pantoprazole β€” C16H15F2N3O4S.

Molecular Weight: Pantoprazole β€” 383.3710 g/mol.

Type: Nivolumab β€” Antibody; Pantoprazole β€” Small molecule.